AIMS OF THE CALL

The overall aim of the call is to fund projects showing clinical feasibility of PM in complex diseases (including multifactorial, monogenic and other diseases). By feasibility is meant the demonstration of significant and clinically relevant improvement of current diagnostics and/or therapeutics, based on improved understanding of underlying molecular mechanisms. Furthermore, applicants are expected to combine pre-clinical and/or clinical research with bio-informatics components to enable data quality on one side and the potential applicability for health care providers on the other side.

The overall objectives of the ERA PerMed call are:

(i) to support translational research projects in the field of Personalised Medicine;

(ii) to encourage and enable interdisciplinarity, in combining pre-clinical and/or clinical research with computational components and;

(iii) to encourage collaboration between academia (research teams from universities, higher education institutions, public research performing institutions), clinical/public health research (research teams from hospital/ public health institutions, healthcare settings and other healthcare organisations) and private partners e.g. SMEs (Small and Medium-size Enterprises).

SCOPE OF THE CALL

Proposals must be interdisciplinary and clearly demonstrate the potential impact in PM as well as the added value of transnational collaboration. Each project proposal needs to tackle the two major research areas:

Research Area 1: “Validation, pre-clinical and clinical biomedical research – Translating Basic to Clinical Research and Beyond”;

Research Area 2: “Data analysis, management and protection – Integrating Big Data and ICT Solutions”

by addressing at least one module out of each research area:

-Module 1A: Pre-clinical Research and/or Module 1B: Clinical Research from Research Area 1.

- Module 2A: Data and ICT – Enabling Technology and/or Module 2B: Data and ICT – Towards application in health care from Research Area 2.Both research areas and the four modules are equal in relevance for this call.

ELIGIBILITY

Only transnational projects will be funded.

Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funding organisations participate to the call (see list below).

The maximum number of partners per project is six though not more than 2 eligible partners from the same country participating in the call will be accepted in one project consortium.

List of elegible countries:

Austria, Canada (Quebec), Croatia, Denmark, Estonia, Finland, France, Germany (Saxon), Hungary, Ireland, Israel, Italy (Lombardy), Latvia, Luxembourg, Netherlands, Norway, Poland, Romania, Slovenia, Spain (Catalonia, Navarre), Sweden and Turkey (contact list is provided in Annex 1).

DEADLINE

The call is planned to be launched in February 2018 with a submission deadline for pre-proposals in April 2018. It is expected, that consortia invited for the full-proposal stage, will need to submit their proposal on July 5th 2018.